The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Sexually Transmitted Disease (STD) Self-Testing Market Over The Period 2026–2030?
The sexually transmitted disease (std) self-testing market has experienced considerable growth in recent years. This market is projected to expand from $1.52 billion in 2025 to $1.67 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. The historic period’s growth can be ascribed to several factors, including limited awareness regarding std testing, the stigma associated with visiting clinics, a reliance on hospital-based testing, an absence of convenient testing options, and the increasing incidence of sexually transmitted diseases.
The sexually transmitted disease (std) self-testing market size is projected to experience substantial expansion over the coming years. This market is anticipated to reach a size of $2.42 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.7%. This anticipated growth during the forecast period is attributable to several factors, including the increasing adoption of digital health platforms, the integration of multi-sample at-home testing kits, escalating government awareness initiatives, a rise in telehealth consultations, and advancements in rapid and accurate diagnostic technologies. Key trends for this period encompass a growing demand for at-home STD testing kits, heightened awareness concerning sexual health and the importance of early diagnosis, the expansion of telehealth and remote consultation services, broader distribution through online and retail pharmacy channels, and the incorporation of multi-sample testing solutions (such as blood, urine, and oral samples).
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25901&type=smp
Which Major Factors Are Driving The Expansion Of The Sexually Transmitted Disease (STD) Self-Testing Market?
An increasing number of syphilis cases is anticipated to drive expansion in the sexually transmitted disease (STD) self-testing market in the future. Syphilis, a sexually transmitted infection, manifests as body sores and can result in severe health complications without proper treatment. This rise in syphilis can be attributed to a reduction in regular condom usage, especially within groups that engage in high-risk sexual activities. Sexually transmitted disease self-testing offers discreet and convenient at-home screening options for syphilis, thereby encouraging early detection. Such timely diagnosis facilitates swift treatment, which helps in reducing complications and halting further transmission. For instance, according to a report from the Centers for Disease Control and Prevention, a US-based government agency, expected around September 2025, roughly 209,253 syphilis cases were reported in 2023, signifying a 1% increase from 207,269 cases in 2022. Consequently, the escalating occurrence of syphilis is stimulating the expansion of the sexually transmitted disease (STD) self-testing market.
How Is The Sexually Transmitted Disease (STD) Self-Testing Market Divided Into Its Major Segments?
The sexually transmitted disease (std) self-testing market covered in this report is segmented –
1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications
Subsegments:
1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device
2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection
3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection
How Are Trends Transforming The Sexually Transmitted Disease (STD) Self-Testing Market Landscape?
Major companies operating in the STD self-testing market are concentrating on developing advanced products, such as over-the-counter (OTC) sample collection kits, to promote early detection and timely treatment of infections. Over-the-counter sample collection kits serve as at-home diagnostic tools that enable individuals to collect samples like urine or swabs without needing a prescription. They offer a convenient and confidential way to identify infections early and facilitate prompt treatment. For instance, in August 2023, iHealth Labs Inc., a US-based digital health company, introduced the CheckMeSafe home collection kit for HIV and syphilis testing. This FDA-approved kit allows individuals aged 18 and older to collect blood samples for HIV (I, II, P24 antigen) and syphilis testing from the comfort and privacy of their own home. Users can mail their samples to the laboratory using a prepaid overnight label and receive confidential, reliable results in as little as two days. The kit provides highly accurate results, with sensitivity rates reaching up to 99.9% for HIV and 99.5% for syphilis. All samples are analyzed in a CLIA-certified and CAP-accredited laboratory, ensuring compliance with strict federal and state quality standards through regular inspections.
Who Are The Prominent Organizations Shaping The Sexually Transmitted Disease (STD) Self-Testing Market?
Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.
Read the full sexually transmitted disease (std) self-testing market report here:
Which Region Currently Holds The Largest Share Of The Sexually Transmitted Disease (STD) Self-Testing Market?
North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sexually Transmitted Disease (STD) Self-Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25901&type=smp
Browse Through More Reports Similar to the Global Sexually Transmitted Disease (STD) Self-Testing Market 2026, By The Business Research Company
Std Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/std-diagnostics-global-market-report
Sexually Transmitted Infections Stis Market Report 2026
Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model